Notably, monoclonal PAX8 and CD5 antibodies are useful in differentiating ITTC from poorly differentiated thyroid carcinoma (PDTC) and squamous cell carcinoma (SCC) (43). Here, PAX8 is linked to poorly differentiated thyroid gland carcinoma.